The global Histology And Cytology Market size is expected to reach USD 37.10 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.74% from 2021 to 2028. The factors contributing to the market growth include an increase in the demand for the early detection of diseases, increased standardization of pathology laboratories, and implementation of immunohistochemistry and innovation in microscopy.
In addition, organizations are collaborating for the
standardization of cytopathology across the world, which is driving the market.
For instance, in May 2020, the International Agency for Research on Cancer
(IARC)entered in collaboration with the International Academy of Cytology (IAC)
for publishing a series of cytopathology reporting systems for presenting an
international approach that can be used for cytopathology of different body
sites. The two organizations are engaged in the expansion and development of
internationally recognized diagnostic reports for cancer and other precancerous
disorders worldwide.
Moreover, companies are launching new and automated
instruments for cytology, which is further contributing to the market growth.
For instance, in January 2021, F. Hoffmann-La Roche Ltd. launched uPath HER2
Dual ISH image analysis and uPath HER2 (4B5) image analysis-two automated
digital pathology algorithms for breast cancer. These two solutions offer rapid
and accurate patient diagnoses in breast cancer.
COVID-19 has become a catalyst for changing
traditional pathology workflows with the integration of artificial
intelligence (AI) and digitalization solutions. During the pandemic, these
tools have helped and continue to assist in remote reviewing of pathological
cases, hence preventing the delay in patient care. Companies have reported the
increasing adoption of digital pathology solutions post-COVID-19.
Related Press Release@ Histology And Cytology Market Report
Histology And Cytology Market
Report Highlights
- Based on type of examination, cytology accounted for the largest
revenue share in 2020 and is expected to maintain its lead in the forecast
period owing to the integration of computational analytical tools for
advancing cytology systems. Histology is expected to witness gradual
growth from2021 to 2028 owing to moderate innovation in histological
systems
- In the cytology segment, by application, the other cancers segment
held the largest share in 2020 owing to the increasing diagnosis of
various cancers such as pancreatic cancer and bile duct cancer with
histopathology and cytopathology. The cervical cancer segment is expected
to witness the fastest growth over the forecast period. Institutes are
integrating computer algorithms for improving the accuracy and efficiency
of cervical cancer screening
- The breast cancer segment held the second-largest share in 2020
owing to the increasing incidence and mortality rates across the globe.
This has resulted in the increasing need for the early diagnosis of breast
cancer, in turn, driving the segment
- By product, the consumable and reagents segment dominated the
market in 2020 owing to the expanding portfolios of the entities operating
in the consumable market space. Instruments and analysis software system
is expected to expand at a substantial CAGR from 2021 to 2028 owing to the
steep increase in the demand for automated histology instruments
- In terms of application, the drug discovery and designing segment accounted
for the largest revenue share in 2020 owing to the growing importance of
cytopathology in disease understanding, further aimed at rapid drug
development
- North America dominated the market in 2020 owing to the prevalence
of cancer, the presence of key players, and developed healthcare
infrastructure
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment